GSK3B and glioma: Moreover, in the present study, changes in mTOR/p70S6K1 signaling pathway occurred in U87 and U251 glioma cells following GSK-3β overexpression, suggesting that this signaling pathway may play an important role in the GSK-3β-inhibited glioma development events.